Advertisement
Financing – November 6, 2024
Thioredoxin Systems (TXN Systems) has announced the close of a Series A financing round to support the development of EbsArgent, the company’s first-in-class bactericidal antibiotic for urinary tract infections (UTIs) caused by antibiotic-resistant bacteria.
Collaboration – November 6, 2024
NLS asked Chiara Facciotto, Innovation Ecosystem Lead at Meilahti Medical Campus, University of Helsinki, and Anu Meerwaldt, Development Manager at SPARK Finland, about the upcoming Y Science event on November 20 and about the start-up climate in Helsinki.
Business article – November 5, 2024
In the summer of 2025, Takeda will move in with about a hundred employees on approx. 830 square meters on floor 2 in Forskaren.
Clinical Trials – November 5, 2024
Medivir has announced a clinical trial collaboration and supply agreement with Eisai to evaluate fostrox in combination with lenvatinib mesylate in a randomized, phase 2b study in second-line advanced liver cancer patients.
Collaboration – November 5, 2024
NEOGAP Therapeutics has entered a strategic collaboration with NorthX Biologics to advance manufacturing strategies for NEOGAP’s personalized cancer cell therapy.
Advertisement
Advertisement
Clinical Trials – November 5, 2024
Medivir has announced a clinical trial collaboration and supply agreement with Eisai to evaluate fostrox in combination with lenvatinib mesylate in a randomized, phase 2b study in second-line advanced liver cancer patients.
Clinical Trials – October 29, 2024
Orexo has announced the first participants have been dosed with OX640, an intranasal rescue medication for severe allergic reactions (incl. anaphylaxis) with powder-based epinephrine, in a new study in subjects with allergic rhinitis (hay fever).
Clinical Trials – October 29, 2024
AroCell has announcd the publication of a study in the European Urology Open Science journal.
Clinical Trials – October 18, 2024
Lundbeck has announced taking one further step in developing treatments for indications in the neuroimmunology and neuroinflammatory space with the initiation of the first clinical trial of its CD40L blocker, Lu AG22515, in patients.
Clinical Trials – September 30, 2024
Cereno Scientific has signed an agreement with medical technology company Fluidda on Respiratory Imaging solutions, with the aim to visualize signs of reverse remodeling of lead drug candidate CS1 in Pulmonary Arterial Hypertension (PAH) in a clinical setting.
Clinical Trials – September 19, 2024
Anocca will present its novel platform approach to therapeutic TCR discovery and preclinical data for its lead TCR-T cell therapy product at the European Society of Medical Oncology (ESMO) Congress 2024.
Agreement – November 4, 2024
Ascendis Pharma has granted Novo Nordisk an exclusive worldwide license to the TransCon technology platform to develop, manufacture and commercialize Novo Nordisk proprietary products in metabolic diseases (including obesity and type 2 diabetes) and a product-by-product exclusive license in cardiovascular diseases.
Biotech Business – October 28, 2024
Takara Bio Europe has announced the expansion of its Gothenburg facility with the addition of a custom manufacturing lab, which came into operation on October 1st.
Pharma Business – October 21, 2024
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending approval of Alhemo (concizumab) as the first once-daily subcutaneous prophylactic treatment for people aged 12 years or older living with haemophilia A or B with inhibitors.
Financing – October 2, 2024
The Board of Directors of Spago Nanomedical has decided that the company’s resources will be focused on the development of Tumorad with the company’s primary priority being the execution of the ongoing clinical study Tumorad-01 with the candidate drug 177Lu-SN201.
Financing – October 2, 2024
The board of directors of Senzime has resolved on a directed share issue of a maximum of 13 873 000 shares at the subscription price of SEK 6.20 per share.
MedTech Business – September 20, 2024
For seriously ill children and adolescents, intravenous drip stands can significantly hinder mobility.
Biotech Business – November 1, 2024
Resalis Therapeutics is headquartered in Turin, Italy, with scientific roots originating from Aalborg University in Denmark and Harvard Medical School in the US.
Biotech Business – October 29, 2024
The study was performed at Testa Center in Uppsala, Sweden, in the 10-liter Xcellerex XDR-10 single-use stirred tank bioreactor (Cytiva).
Biotech Business – October 21, 2024
BioArctic’s partner Eisai has announced that the Therapeutic Goods Administration (TGA) of Australia issued a public statement about the initial decision not to register the humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody lecanemab for the treatment of patients with mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) and mild AD dementia.
Science – July 8, 2024
Unfortunately genes do matter when it comes to obesity, but knowledge about these genes and how they work are key to improving treatment and prevention.
Profiles in Science – June 18, 2024
Anna Falk, Head of Lund University’s Center for Advanced Therapies (LU-ATMP) and principal researcher of the Department of Neuroscience at Karolinska Institutet (KI) shares insights into her research, her multi-faceted job, and her vision for the future of neuroscience. Anna Falk is a molecular biologist with a PhD in neural stem cells and adult neurogenesis. […]
Science – September 20, 2023
An international team of scientists led by the University of Helsinki performed comprehensive mapping of structural alterations in cellular proteins during the aging process. In the study published in Molecular Cell, the team mapped structural alterations in cellular proteins during the aging process and, in the process, identifying new ways aging impacts how cells hum […]
Stryker
In this role, you will help us deliver on our mission of making healthcare better by promoting and selling Stryker’s world-class Neurovascular product portfolio. You will cover the Swedish territory.
Stryker
As a Territory Sales Manager being responsible for our Upper Extremities portfolio, you’ll help us deliver on our mission of making healthcare better by promoting and selling Stryker’s world-class Orthopaedic medical devices
Orifarm
The Company In Orifarm, they aim to bring healthy days by making modern healthcare a better deal for the people and the societies they serve. Everyone should have access to modern medicine. High costs or lack of access to pharmaceuticals should never impact possibility to receive treatment or relief and live a healthy life. Working […]
Ropox
The Company Giving people with disabilities a better life is core for Ropox. People with limited mobility deserve a life where they have the ability and freedom to safely take care of themselves.At the same time, their careers need optimum working conditions so they can spend their time where it is needed the most. Everything […]
Stryker
Are you ready to drive the market and new product development strategies for a cutting-edge global med tech product?
Haeger & Carlsson
On behalf of our customer, a Swedish biotech company in a very exciting phase of its development, Haeger&Carlsson recruits the company’s new CFO.
In a new job – November 4, 2024
Åsa Uppströmer joins PharmaRelations from a position as branch manager for the Stockholm area in the large Frensch IT consulting group, Sogeti, part of the French listed giant Cap Gemini.
In a new job – October 11, 2024
BerGenBio has announced that CEO, Martin Olin will be leaving the company to pursue other opportunities.
In a new job – October 10, 2024
Sofia Mayans, who transitioned from her research to co-founding InfiCure Bio, is taking on a new role as Director of Business Development at Diamyd Medical in Umeå.
Careers article – October 14, 2024
Sweden boasts a global reputation for cutting-edge research and innovation, but the country’s ambition to maintain its leading position as an innovation nation faces a significant challenge: securing and retaining top talent from abroad. Why then is the route to work permits for international professionals complex and lengthy?
Careers article – October 11, 2024
Besides her technical knowledge in clinical development and clinical operations, leading and managing company and regulatory agencies’ teams has been a core aspect of Margrethe Sørgaard’s career path.
Careers article – August 12, 2024
Getting back to work after a long and relaxing holiday can be quite hard, here is some advice to make things easier and make your return less stress-free. 1. Plan your return Most people focus on getting organized for departure, perhaps maximizing their time away and then comes home just the day before work begins. […]
Profiles in Business – April 23, 2024
Despite being the co-founder of Ilya Pharma and co-director at the Science for Life Laboratory (SciLifeLab), Dr. Mia Phillipson, considers herself a scientist foremost, not an entrepreneur. “Most of all, I am a scientist. Yes, absolutely. This is my main occupation and the one in which I have the most expertise,” says Mia Phillipson, who […]
Business article – April 17, 2024
Personalized medicine, weight loss remedies and new treatments for widespread ailments are among the rising areas of high interest in the biotechnology and therapeutic arenas, according to executive chairman of Flerie Invest, Thomas Eldered. Thomas Eldered talked with Nordic Life Science about the Nordic and global life science financial landscapes and Flerie’s role in funding […]
Business – November 28, 2023
The previous founder and CEO of BioLamina has gone back to business development, and with his newly founded company he aims to redefine cell therapy development even further. Newly founded Alder Therapeutics is a preclinical phase stem cell therapy development company and, according to Kristian Tryggvason, co-founder and CEO, it is “the next big thing.” […]
This site uses cookies
